An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease

Katharine Gupta; Jane Estrella; Rohit Rajagopal; Praseetha Shanmugalingam; David Simmons

doi:10.1002/ccr3.1022

An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease

Katharine Gupta, Jane Estrella, Rohit Rajagopal, Praseetha Shanmugalingam, David Simmons

Western Sydney University

Research output: Contribution to journal › Article › peer-review

Abstract

Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves' thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.

Original language	English
Pages (from-to)	1226-1229
Number of pages	4
Journal	Clinical Case Reports
Volume	5
Issue number	8
DOIs	https://doi.org/10.1002/ccr3.1022
Publication status	Published - 2017

Open Access - Access Right Statement

© 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords

Graves' disease
diphosphonates
endocrinology
hypercalcemia
hyperthyroidism

Access to Document

10.1002/ccr3.1022

Cite this

@article{a75e40977b6a423c836df92c6cd0f8ba,

title = "An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease",

abstract = "Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves' thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.",

keywords = "Graves' disease, diphosphonates, endocrinology, hypercalcemia, hyperthyroidism",

author = "Katharine Gupta and Jane Estrella and Rohit Rajagopal and Praseetha Shanmugalingam and David Simmons",

year = "2017",

doi = "10.1002/ccr3.1022",

language = "English",

volume = "5",

pages = "1226--1229",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

TY - JOUR

T1 - An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease

AU - Gupta, Katharine

AU - Estrella, Jane

AU - Rajagopal, Rohit

AU - Shanmugalingam, Praseetha

AU - Simmons, David

PY - 2017

Y1 - 2017

N2 - Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves' thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.

AB - Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves' thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.

KW - Graves' disease

KW - diphosphonates

KW - endocrinology

KW - hypercalcemia

KW - hyperthyroidism

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:41348

U2 - 10.1002/ccr3.1022

DO - 10.1002/ccr3.1022

M3 - Article

SN - 2050-0904

VL - 5

SP - 1226

EP - 1229

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 8

ER -

An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves' disease

Abstract

Open Access - Access Right Statement

Keywords

Access to Document

Other files and links

Fingerprint

Cite this